Wu P, Li G, Guo D, Guo T, Chai C
J Cancer. 2025; 16(2):486-495.
PMID: 39744479
PMC: 11685701.
DOI: 10.7150/jca.100556.
Zhang Y, Liang Y, Wu Y, Song L, Zhang Z
Oncol Res. 2024; 32(11):1747-1763.
PMID: 39449799
PMC: 11497179.
DOI: 10.32604/or.2024.030945.
Ismail M, Fadul M, Taha R, Siddig O, Elhafiz M, Yousef B
Hepatol Int. 2024; 18(6):1715-1730.
PMID: 39306594
DOI: 10.1007/s12072-024-10722-1.
Zhang H, Zhu J, Zhang J, Liu Y, Zhao B, Yang X
Heliyon. 2024; 10(16):e36282.
PMID: 39253193
PMC: 11381758.
DOI: 10.1016/j.heliyon.2024.e36282.
Chan Y, Zhang C, Wu J, Lu P, Xu L, Yuan H
Mol Cancer. 2024; 23(1):189.
PMID: 39242496
PMC: 11378508.
DOI: 10.1186/s12943-024-02101-z.
Copper Isotope Evidence of Oxidative Stress-Induced Hepatic Breakdown and the Transition to Hepatocellular Carcinoma.
Telouk P, Plissonnier M, Merle P, Zoulim F, Fares N, Guilloreau P
Gastro Hep Adv. 2024; 1(3):480-486.
PMID: 39131686
PMC: 11307693.
DOI: 10.1016/j.gastha.2022.02.024.
Cross talk between genetics and biochemistry in the pathogenesis of hepatocellular carcinoma.
Ucdal M, Burus A, Celtikci B
Hepatol Forum. 2024; 5(3):150-160.
PMID: 39006147
PMC: 11237245.
DOI: 10.14744/hf.2023.2023.0028.
MA-mediated upregulation of lncRNA TUG1 in liver cancer cells regulates the antitumor response of CD8 T cells and phagocytosis of macrophages.
Xi Q, Yang G, He X, Zhuang H, Li L, Lin B
Adv Sci (Weinh). 2024; 11(34):e2400695.
PMID: 38981064
PMC: 11425850.
DOI: 10.1002/advs.202400695.
Classification of Long Non-Coding RNAs s Between Early and Late Stage of Liver Cancers From Non-coding RNA Profiles Using Machine-Learning Approach.
Anuntakarun S, Khamjerm J, Tangkijvanich P, Chuaypen N
Bioinform Biol Insights. 2024; 18:11779322241258586.
PMID: 38846329
PMC: 11155358.
DOI: 10.1177/11779322241258586.
FOXD2-AS1 promotes malignant cell behavior in oral squamous cell carcinoma via the miR-378 g/CRABP2 axis.
Guo S, Huang B, You Z, Luo Z, Xu D, Zhang J
BMC Oral Health. 2024; 24(1):625.
PMID: 38807101
PMC: 11134640.
DOI: 10.1186/s12903-024-04388-2.
The regulation of hypoxia-related lncRNAs in hepatocellular carcinoma.
Wang X, Wang X
Discov Oncol. 2024; 15(1):144.
PMID: 38713276
PMC: 11076439.
DOI: 10.1007/s12672-024-01002-3.
Analysis of the longitudinal stability of human plasma miRNAs and implications for disease biomarkers.
Sandau U, Wiedrick J, McFarland T, Galasko D, Fanning Z, Quinn J
Sci Rep. 2024; 14(1):2148.
PMID: 38272952
PMC: 10810819.
DOI: 10.1038/s41598-024-52681-5.
Circ_MAPK9 promotes STAT3 and LDHA expression by silencing miR-642b-3p and affects the progression of hepatocellular carcinoma.
Wang K, Lu Q, Luo Y, Yu G, Wang Z, Lin J
Biol Direct. 2024; 19(1):4.
PMID: 38163874
PMC: 10759731.
DOI: 10.1186/s13062-023-00442-1.
Hepatocellular carcinoma extracellular vesicle ECG score as a diagnostic tool close to the ideal.
Slomka A, Mocan T, Willms A, Lukacs-Kornek V, Kornek M
Hepatobiliary Surg Nutr. 2023; 12(6):930-932.
PMID: 38115928
PMC: 10727809.
DOI: 10.21037/hbsn-23-509.
LncRNA CECR7 boosts hepatocellular carcinoma progression by recruiting RNA binding protein U2AF2 to enhance the stability of EXO1 mRNA.
Zhao L, Zang Q, Liang G, Yao X
Heliyon. 2023; 9(9):e19862.
PMID: 37809785
PMC: 10559240.
DOI: 10.1016/j.heliyon.2023.e19862.
Prediction of prognosis, immune infiltration, and personalized treatment of hepatocellular carcinoma by analysis of cuproptosis-related long noncoding RNAs and verification .
Li S, Zhu Z, Lu J, Cao W, Song F, Xiao C
Front Oncol. 2023; 13:1159126.
PMID: 37746284
PMC: 10514553.
DOI: 10.3389/fonc.2023.1159126.
MicroRNA (miR)-124: A Promising Therapeutic Gateway for Oncology.
Gourishetti K, Easwaran V, Mostakim Y, Pai K, Bhere D
Biology (Basel). 2023; 12(7).
PMID: 37508353
PMC: 10376116.
DOI: 10.3390/biology12070922.
Identification of an immune-related 6-lncRNA panel with a good performance for prognostic prediction in hepatocellular carcinoma by integrated bioinformatics analysis.
Lu S, Liu X, Wu C, Zhang J, Stalin A, Huang Z
Medicine (Baltimore). 2023; 102(29):e33990.
PMID: 37478241
PMC: 10662904.
DOI: 10.1097/MD.0000000000033990.
A nomogram based on 4-lncRNAs signature for improving prognostic prediction of hepatocellular carcinoma.
Mo Q, Li W, Liu L, Hao Z, Jia S, Duo Y
Clin Transl Oncol. 2023; 26(2):375-388.
PMID: 37368201
DOI: 10.1007/s12094-023-03244-z.
Mechanisms of portal vein tumour thrombus formation and development in patients with hepatocellular carcinoma.
Li Z, Zhao M, Qi X, Tang Y, Cheng S
J Cell Mol Med. 2023; 27(15):2103-2111.
PMID: 37349905
PMC: 10399540.
DOI: 10.1111/jcmm.17808.
